Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease. Hydes TJ, Lip GYH, Lane DA. Circulation 2023;147:795-797.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hydes TJ, Lip GYH, Lane DA. Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease. Circulation 2023;147:795-797.
PMID: 36877772